Tumor News and Research

RSS

Study finds new marker to detect fatal breast cancer

A new study conducted at the University College London, UK, found a new marker that has the capacity to help diagnose fatal breast cancer up to one year earlier than existing methods.

22 Dec 2017

Higher ‘mutational burden’ of tumors predicts success rate with cancer immunotherapies

The "mutational burden," or the number of mutations present in a tumor's DNA, is a good predictor of whether that cancer type will respond to a class of cancer immunotherapy drugs known as checkpoint inhibitors, a new study led by Johns Hopkins Kimmel Cancer Center researchers shows.

21 Dec 2017

Specific diets may help prevent colorectal cancer in high-risk groups

Colorectal cancer is the most prevalent malignant tumor in Spain. It is known that factors such as diet and intestinal inflammation play an important role in its occurrence, but direct links between nutrients, inflammation and colorectal cancer are poorly described.

21 Dec 2017

Medicaid expansion improves early-stage cancer detection, research shows

The Affordable Care Act led to an increase in the number of cancer diagnoses -- particularly those at early stages -- in states where Medicaid was expanded, according to research from Indiana University.

21 Dec 2017

Tumor growth traits can influence response to cancer drugs, study finds

Individual tumors respond differently to cancer drugs, if at all. Until now, it remained a mystery why tumors have different reactions to the exact same therapy. But a new study at the USC Viterbi School of Engineering finds that tumor growth properties can influence response to cancer drugs.

21 Dec 2017

Loss of specific protein makes breast cancers more aggressive, resistant to chemotherapy

Researchers in Italy have discovered how specific versions of a protein called Numb protect the key tumor suppressor p53 from destruction.

21 Dec 2017

Novel drug shows promise in treating metastatic kidney cancer

Metastatic kidney cancer remains largely incurable. Despite a dozen treatments and several immunotherapies, survival rates beyond 5 years remain around 10 percent.

21 Dec 2017

Nanomedicine platform can guide doctors to remove tumors and kill malignant cells

Oregon State University scientists have developed a nanomedicine platform for cancer that can help doctors know which tissue to cut out as well as kill any malignant cells that can't be surgically removed.

21 Dec 2017

K2M wins CE Mark for CAPRI Cervical 3D Expandable Corpectomy Cage System

K2M Group Holdings, Inc., a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional Total Body Balance™, today announced that it received a CE Mark for its CAPRI Cervical 3D Expandable Corpectomy Cage System featuring Lamellar 3D Titanium Technology™, and the successful completion of its first surgical case.

21 Dec 2017

Study findings could lead to less expensive and more effective cancer treatments

The latest generation of cancer treatments spring from the discovery that the human immune system is able to beat the disease. Like Dorothy in "The Wizard of Oz," what research teams around the world have spent decades searching for was right in their own backyard all along.

20 Dec 2017

Certain brain tumor patients more likely to receive short hospice services, study finds

While more than 60 percent of patients with the brain tumors called malignant gliomas enroll in hospice services, almost a quarter of them do so within a week of death, probably too late for patients and family members to benefit from hospice care.

20 Dec 2017

Stem cells remain healthy following low-dose X-ray exposure, say biophysicists

Biophysicists have shown that following low-dose exposure to X-rays (at 80 milligrays), stem cells remain healthy, proliferate, and do not accumulate DNA damage to be passed on to their progeny. The paper was published in the journal Aging.

20 Dec 2017

Scientists find sperm as potential drug carrier to treat gynecological conditions

Delivering drugs specifically to cancer cells is one approach researchers are taking to minimize treatment side effects. Stem cells, bacteria and other carriers have been tested as tiny delivery vehicles.

20 Dec 2017

Ludwig study elucidates mechanism behind metabolic vulnerability of some breast tumors

Scientists have known since the 1980s that many cancer cells are relatively sensitive to the deprivation of an essential amino acid known as methionine. It has, however, long been unclear what causes such marked dependency on methionine.

20 Dec 2017

Study identifies potential markers for early diagnosis, treatment of oral tongue cancer

Squamous cell carcinoma of the tongue, also known as oral tongue cancer, is an aggressive form of cancer that generally affects older people. Patients with the disease often find it difficult to eat, swallow food, or speak.

19 Dec 2017

Dysfunctional gene may be cause of Crohn's disease in some patients

This holiday season, millions of people will gather at airports ready to board planes for destinations around the world. Depending on the environment at their destination, their suitcases may be filled with sunscreen and bathing suits, or heavy parkas and mittens.

19 Dec 2017

New scalp device delivering electric fields improves survival in patients with glioblastoma

A device attached to a patient's scalp that delivers a continuous dose of low-intensity electric fields improves survival and slows the growth of a deadly brain tumor, according to a new clinical trial led by a Northwestern Medicine scientist and published Dec. 19 in the journal JAMA.

19 Dec 2017

Study finds combination therapy as effective strategy to treat ovarian cancers

Researchers at The Wistar Institute have found that combining PARP inhibitors, recently approved for the treatment of BRCA-mutant ovarian cancer, with another small molecule inhibitor was effective to treat ovarian cancers without BRCA1 and BRCA2 gene mutations.

19 Dec 2017

Electric fields therapy leads to better overall, progression-free survival in glioblastoma patients

Patients with glioblastoma, an aggressive brain tumor who received a type of electric fields therapy that interferes with cell division had better overall survival and survival without progression of the tumor compared to standard chemotherapy.

19 Dec 2017

Treatment for skin cancer could be more effective if combined with arthritis drug

Treatment for the most deadly form of skin cancer could be more effective if combined with a well-known drug for rheumatoid arthritis, new research has shown.

19 Dec 2017

Tumor News and Research

Study finds new marker to detect fatal breast cancer

Higher ‘mutational burden’ of tumors predicts success rate with cancer immunotherapies

Specific diets may help prevent colorectal cancer in high-risk groups

Medicaid expansion improves early-stage cancer detection, research shows

Tumor growth traits can influence response to cancer drugs, study finds

Loss of specific protein makes breast cancers more aggressive, resistant to chemotherapy

Novel drug shows promise in treating metastatic kidney cancer

Nanomedicine platform can guide doctors to remove tumors and kill malignant cells

K2M wins CE Mark for CAPRI Cervical 3D Expandable Corpectomy Cage System

Study findings could lead to less expensive and more effective cancer treatments

Certain brain tumor patients more likely to receive short hospice services, study finds

Stem cells remain healthy following low-dose X-ray exposure, say biophysicists

Scientists find sperm as potential drug carrier to treat gynecological conditions

Ludwig study elucidates mechanism behind metabolic vulnerability of some breast tumors

Study identifies potential markers for early diagnosis, treatment of oral tongue cancer

Dysfunctional gene may be cause of Crohn's disease in some patients

New scalp device delivering electric fields improves survival in patients with glioblastoma

Study finds combination therapy as effective strategy to treat ovarian cancers

Electric fields therapy leads to better overall, progression-free survival in glioblastoma patients

Treatment for skin cancer could be more effective if combined with arthritis drug

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News